VSTM2L is a novel secreted antagonist of the neuroprotective peptide Humanin
Open Access
- 24 February 2011
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 25 (6), 1983-2000
- https://doi.org/10.1096/fj.10-163535
Abstract
Humanin (HN) is a 24-residue peptide displaying a protective activity in vitro against a range of cytotoxic and neurotoxic insults, as well as mediating in vivo amelioration of Alzheimer disease (AD)-related memory impairment in experimental models. Published evidence suggests that the mechanisms through which HN exerts its cyto- and neuroprotective activity may include its secretion and binding to membrane-associated receptors. Here, we describe the identification of a new modulator of HN neuroprotective activity, V-set and transmembrane domain containing 2 like (VSTM2L), previously known as C20orf102. VSTM2L interacts with HN in both yeast and mammalian cells, is secreted in cultured cells, is present in serum, and is selectively expressed in the central nervous system. VSTM2L colocalizes with HN in distinct brain areas as well as in primary cultured neurons, where it plays a role in the modulation of neuronal viability. When tested in HN neuroprotection bioassays, VSTM2L acts as a strong antagonist of HN neuroprotective activity. In summary, VSTM2L is the first example of a secreted antagonist of HN and may play a role in the modulation of HN biological functions.—Rossini, L., Hashimoto, Y., Suzuki, H., Kurita, M., Gianfriddo, M., Scali, C., Roncarati, R., Scali, C., Franceschini, D. Scali, C., Pollio, G., Trabalzini, L., Roncarati, R., Scali, C., Terstappen, G. C., Scali, C., Matsuoka, M., Scali, C., Caricasole, A. VSTM2L is a novel secreted antagonist of the neuroprotective peptide Humanin. FASEB J. 25, 1983–2000 (2011). www.fasebj.orgKeywords
This publication has 41 references indexed in Scilit:
- Autosomal dominant cerebellar ataxias: polyglutamine expansions and beyondThe Lancet Neurology, 2010
- Humanin: A Novel Central Regulator of Peripheral Insulin ActionPLOS ONE, 2009
- Humanin Inhibits Neuronal Cell Death by Interacting with a Cytokine Receptor Complex or Complexes Involving CNTF Receptor α/WSX-1/gp130Molecular Biology of the Cell, 2009
- Neuroprotective effect of humanin on cerebral ischemia/reperfusion injury is mediated by a PI3K/Akt pathwayBrain Research, 2008
- Interleukin-3 prevents neuronal death induced by amyloid peptideBMC Neuroscience, 2007
- A functional map of NFκB signaling identifies novel modulators and multiple system controlsGenome Biology, 2007
- Comparative genomics modeling of the NRSF/REST repressor network: From single conserved sites to genome-wide repertoireGenome Research, 2006
- Involvement of tyrosine kinases and STAT3 in Humanin-mediated neuroprotectionLife Sciences, 2005
- Mechanisms of Neuroprotection by a Novel Rescue Factor Humanin from Swedish Mutant Amyloid Precursor ProteinBiochemical and Biophysical Research Communications, 2001
- A novel genetic system to detect protein–protein interactionsNature, 1989